Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).

Valenti M, Ingurgio RC, Ibba L, Cammarata E, Caposiena Caro RD, Carugno A, Dragotto M, Marasca C, Malagoli P, Martora F, Marzano AV, Megna M, Mercuri SR, Messina F, Michelucci A, Moltrasio C, Paolino G, Repetto F, Ribero S, Rossiello L, Trovato E, Zerbinati N, Costanzo A, Narcisi A, Dini V, Italian Landscape HS (IL-HS) Study Group

Open source

DOI: 10.1007/s13555-026-01891-y
Published: 2026 Aug 28
Container: Dermatology and therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01891-y,
  title = {Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).},
  author = {Valenti M and Ingurgio RC and Ibba L and Cammarata E and Caposiena Caro RD and Carugno A and Dragotto M and Marasca C and Malagoli P and Martora F and Marzano AV and Megna M and Mercuri SR and Messina F and Michelucci A and Moltrasio C and Paolino G and Repetto F and Ribero S and Rossiello L and Trovato E and Zerbinati N and Costanzo A and Narcisi A and Dini V and Italian Landscape HS (IL-HS) Study Group},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01891-y},
  url = {https://doi.org/10.1007/s13555-026-01891-y}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).
AU  - Valenti M
AU  - Ingurgio RC
AU  - Ibba L
AU  - Cammarata E
AU  - Caposiena Caro RD
AU  - Carugno A
AU  - Dragotto M
AU  - Marasca C
AU  - Malagoli P
AU  - Martora F
AU  - Marzano AV
AU  - Megna M
AU  - Mercuri SR
AU  - Messina F
AU  - Michelucci A
AU  - Moltrasio C
AU  - Paolino G
AU  - Repetto F
AU  - Ribero S
AU  - Rossiello L
AU  - Trovato E
AU  - Zerbinati N
AU  - Costanzo A
AU  - Narcisi A
AU  - Dini V
AU  - Italian Landscape HS (IL-HS) Study Group
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01891-y
UR  - https://doi.org/10.1007/s13555-026-01891-y
ER  -

APA

M, V., RC, I., L, I., E, C., RD, C. C., A, C., M, D., C, M., P, M., F, M., AV, M., M, M., SR, M., F, M., A, M., C, M., G, P., F, R., S, R., L, R., E, T., N, Z., A, C., A, N., V, D., & Group, I. L. H. (. S. (2026). Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01891-y

Source records

pubmed · retrieved 2026-09-26T06:27:33.466Z